School Of Medicine At Mount Sinai Icahn Renalytix PLC (RNLX) insider trading activity

School Of Medicine At Mount Sinai Icahn is of Renalytix plc. Currently has a direct ownership of 32.7 Million shares of RNLX, which is worth approximately $4.9 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 13,366,750 shares (Ordinary Shares) at a price of $0.12 per share, resulting in proceeds of $1,604,010. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.7M

69.2% 3M change

n/a 12M change

Total Value Held $4.9 Million

SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 01 2024	BUY Other acquisition or disposition	$1,604,010 $0.12 p/Share	13,366,750 Added 29.03%	32,683,998 Ordinary Shares
Apr 24 2024	BUY Other acquisition or disposition	$2,340,093 $0.25 p/Share	9,360,374 Added 32.64%	19,317,248 Ordinary Shares

Also insider at

SMFR

Sema4 Holdings Corp. Healthcare

SOM